AI

How DeepSeek founder's quant empire is taking on China's choppy IPO boom

Aug 27, 2026 - 21:15
 0  0
How DeepSeek founder's quant empire is taking on China's choppy IPO boom
High-Flyer Quant, which bankrolled DeepSeek, has come to the fore, making a push into new listings as it chases returns in China's red-hot IPO market. 

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0

Related Posts

Health insurance premiums and deductibles are projected to rise in 2027 as employers and ACA insurers face higher costs, with median proposed marketplace premiums up 15% and employer health costs rising sharply.

Health insurance premiums and deductibles are projected...

Oct 2, 2026  0  0

AI is reshaping the creator economy: influencers are weighing lucrative five- to seven-figure promotions from companies like OpenAI, Meta, Anthropic and Google against the risk of alienating fans who trust them.

AI is reshaping the creator economy: influencers are we...

Oct 2, 2026  0  0

The FAA says a software glitch in certain Boeing 737 Max flight computers is not a flight-safety issue, clearing a path toward certification of the 737 Max 10 and prompting a bulletin to airlines.

The FAA says a software glitch in certain Boeing 737 Ma...

Oct 2, 2026  0  0

Anthropic is investing $100 million in Claude Frontier Academy to train 10,000 deployed AI engineers by the end of 2027, with the first certified engineers expected in early 2027.

Anthropic is investing $100 million in Claude Frontier ...

Oct 2, 2026  0  0

A Pentagon watchdog says some elite Navy SWCC boat crews may be returning to dangerous missions with undiagnosed brain injuries because of gaps in reporting, screening and follow-up care.

A Pentagon watchdog says some elite Navy SWCC boat crew...

Oct 2, 2026  0  0

Eli Lilly and Novo Nordisk are developing amylin-based obesity drugs to complement GLP-1 medicines, as Lilly reported Phase 2 data showing eloralintide plus tirzepatide led to 23.3% weight loss at 48 weeks.

Eli Lilly and Novo Nordisk are developing amylin-based ...

Oct 2, 2026  0  0